Lack of clarity from officials delay providers' efforts to ensure clinical decision support tools don't discriminate.

For years, Pfizer was the only drugmaker with treatments for the disease, called ATTR-CM, but BridgeBio’s CEO said in an ...

In a significant move, the NIH said it would reduce its reliance on animals in federally funded research and instead ...

Novartis is buying Regulus for $800 million, picking up the biotech's experimental kidney drug that's based off a ...

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Usha Lee McFarling ...

Here are eight possible indicators of how health secretary Robert F. Kennedy Jr. may handle U.S. vaccine policy in coming ...

The drug cytisinicline could help expand options for quitting smoking, and if approved by the FDA, would be the first new ...

Twenty years after the debates of the George W. Bush era, there appears to be a serious threat that all government human ...

As medical schools struggle to source cadavers ethically and affordably, many are turning to technology instead. That, one ...

We’d like to introduce you to the fellow above, whose name is Jae. When asked what area of study she specializes in, she only ...

This is the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and ...

FDA vaccine oversight is shifting, with increased scrutiny and mixed messaging sparking concerns among health experts.